BTAI BioXcel Therapeutics, Inc.
Price Chart
Executive Summary
Three top insiders at BioXcel Therapeutics (CEO, CFO, and another executive) collectively sold $35.6K in open-market shares on May 20, 2026, at ~$1.08/share. This cluster follows the Q1 earnings release (May 15) showing $17.2M cash and ~4 months runway, and the company's engagement of MTS Health Partners to explore strategic options. The sales are small relative to the $35M market cap (~0.1%), but the CEO and CFO selling simultaneously after a cash-burn warning and strategic review is a cautionary signal.
Key Financial Metrics
Actionable Insight
The CEO and CFO selling within a week of disclosing a cash crisis and strategic review is a bearish signal, even if dollar amounts are small. Monitor for a dilutive offering or unfavorable strategic outcome (e.g., distressed sale). The PDUFA date of Nov 14, 2026 for IGALMI at-home use is a binary catalyst but cash runway may not last that long without financing.
Key Facts
- CEO Vimal Mehta sold 19,419 shares for ~$21.1K at $1.087/share on May 20, 2026.
- CFO Richard Steinhart sold 6,845 shares for ~$7.4K at $1.085/share on May 20, 2026.
- Executive Javier Rodriguez sold 6,560 shares for ~$7.1K at $1.084/share on May 20, 2026.
- Total insider sales of $35.6K represent ~0.1% of BTAI's $35M market cap.
- Q1 2026 cash burn reduced cash from $28.8M to $17.2M, implying ~4 months of runway.
- Company engaged MTS Health Partners to explore strategic options including a potential sale.
Financial Impact
Insider sales of $35.6K, or ~0.1% of market cap — modest in absolute terms but notable for CEO/CFO simultaneous selling.
Risk Factors
- Cash runway of ~4 months may force dilutive equity offering or distressed sale.
- Insider selling by CEO and CFO suggests limited confidence in near-term stock upside.
- Strategic review (MTS Health Partners) could result in unfavorable terms for common shareholders.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-BTAI-1779490939029 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 22, 2026
18d ago
|
Insider Cluster
| $1.22 $1.19 | ▲ +2.46% | ▲ +3.67% | $1.11 (+9.43%) |
|
May 20, 2026
20d ago
|
144
| $1.14 $1.17 | ▲ +2.63% | ▲ +0.78% | $1.11 (−3.07%) |
|
May 15, 2026
25d ago
|
8-K
| $1.14 $1.13 | ▼ −0.88% | ▼ −1.84% | $1.11 (−3.07%) |
|
May 15, 2026
25d ago
|
Press Release
| $1.14 $1.13 | ▲ +0.88% | ▲ +1.84% | $1.11 (+3.07%) |
|
Apr 17, 2026
7w ago
|
8-K
| $1.20 $1.09 | ▲ +9.17% | ▲ +10.08% | $1.11 (+7.92%) |
|
Mar 27, 2026
10w ago
|
Press Release
| $1.26 $1.14 | ▼ −9.52% | ▼ −13.39% | $1.11 (−12.30%) |
|
Mar 11, 2026
12w ago
|
8-K
| $1.55 $1.60 | ▲ +3.23% | ▲ +4.20% | $1.11 (−28.71%) |
|
Mar 10, 2026
13w ago
|
Press Release
| $1.55 $1.73 | ▼ −11.61% | ▼ −12.52% | $1.11 (+28.71%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access